Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study

The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation among cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profilin...

Descripción completa

Detalles Bibliográficos
Autores principales: Au, Lewis, Boos, Laura Amanda, Swerdlow, Anthony, Byrne, Fiona, Shepherd, Scott T.C., Fendler, Annika, Turajlic, Samra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470737/
https://www.ncbi.nlm.nih.gov/pubmed/32979319
http://dx.doi.org/10.1016/j.cell.2020.09.005
_version_ 1783578638035189760
author Au, Lewis
Boos, Laura Amanda
Swerdlow, Anthony
Byrne, Fiona
Shepherd, Scott T.C.
Fendler, Annika
Turajlic, Samra
author_facet Au, Lewis
Boos, Laura Amanda
Swerdlow, Anthony
Byrne, Fiona
Shepherd, Scott T.C.
Fendler, Annika
Turajlic, Samra
author_sort Au, Lewis
collection PubMed
description The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation among cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profiling study designed to address this knowledge gap.
format Online
Article
Text
id pubmed-7470737
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74707372020-09-04 Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study Au, Lewis Boos, Laura Amanda Swerdlow, Anthony Byrne, Fiona Shepherd, Scott T.C. Fendler, Annika Turajlic, Samra Cell Commentary The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation among cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profiling study designed to address this knowledge gap. Elsevier Inc. 2020-10-01 2020-09-03 /pmc/articles/PMC7470737/ /pubmed/32979319 http://dx.doi.org/10.1016/j.cell.2020.09.005 Text en © 2020 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Au, Lewis
Boos, Laura Amanda
Swerdlow, Anthony
Byrne, Fiona
Shepherd, Scott T.C.
Fendler, Annika
Turajlic, Samra
Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study
title Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study
title_full Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study
title_fullStr Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study
title_full_unstemmed Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study
title_short Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study
title_sort cancer, covid-19, and antiviral immunity: the capture study
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470737/
https://www.ncbi.nlm.nih.gov/pubmed/32979319
http://dx.doi.org/10.1016/j.cell.2020.09.005
work_keys_str_mv AT aulewis cancercovid19andantiviralimmunitythecapturestudy
AT booslauraamanda cancercovid19andantiviralimmunitythecapturestudy
AT swerdlowanthony cancercovid19andantiviralimmunitythecapturestudy
AT byrnefiona cancercovid19andantiviralimmunitythecapturestudy
AT shepherdscotttc cancercovid19andantiviralimmunitythecapturestudy
AT fendlerannika cancercovid19andantiviralimmunitythecapturestudy
AT turajlicsamra cancercovid19andantiviralimmunitythecapturestudy
AT cancercovid19andantiviralimmunitythecapturestudy

Ejemplares similares